Catalina Lopez-Correa
Directeur Technique/Scientifique/R&D chez Algae-C, Inc.
Postes actifs de Catalina Lopez-Correa
Sociétés | Poste | Début | Fin |
---|---|---|---|
Algae-C, Inc.
Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Directeur/Membre du Conseil | - | - |
Directeur Technique/Scientifique/R&D | - | - |
Historique de carrière de Catalina Lopez-Correa
Anciens postes connus de Catalina Lopez-Correa
Sociétés | Poste | Début | Fin |
---|---|---|---|
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 01/01/2016 | 01/10/2019 |
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Directeur Technique/Scientifique/R&D | 21/07/2011 | - |
Formation de Catalina Lopez-Correa
Pontifical Bolivarian University | Doctorate Degree |
Katholieke Universiteit Leuven | Doctorate Degree |
Statistiques
Internationale
Canada | 4 |
Colombie | 2 |
Belgique | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 2 |
Director/Board Member | 1 |
Sectorielle
Commercial Services | 3 |
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Genome British Columbia
Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Commercial Services |
Algae-C, Inc.
Algae-C, Inc. BiotechnologyHealth Technology Algae-C, Inc. is a Canadian biotech company that specializes in developing and producing high-value active pharmaceutical ingredients using microalgae. Algae-C's high-value molecules are economical and environmentally sustainable, with applications in the pharmaceutical, nutraceutical, and therapeutic industries. The company's technology addresses multiple manufacturing challenges, including increased drug ingredient costs, supply chain risk, and high environmental impacts. Algae-C's platform is naturally carbon negative and intrinsically reduces risk and cost. The company creates designer algae that produce valuable plant-based ingredients for various industries. The company was founded in 2014 and is the largest algae biosynthetic research company in Canada, with over 34 dedicated researchers, including 16 PhDs. The company was founded in 2015 by Mather A. Carscallen, who has been the CEO since then. | Health Technology |
- Bourse
- Insiders
- Catalina Lopez-Correa
- Expérience